Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Serine protease inhibitors identified by researchers at AxyS

Aug. 24, 2001

Preliminary phase III results of IM-862 in KS disappointing

Aug. 24, 2001

Phase II/III study of Onco TCS passes safety review

Aug. 24, 2001

Roche discloses antiproliferative derivatives useful for the treatment of solid tumors

Aug. 23, 2001

Corixa and GSK submit complete response to FDA for Bexxar

Aug. 23, 2001

Praecis announces meeting date with FDA regarding Plenaxis NDA

Aug. 23, 2001

Two antiangiogenesis agents from EntreMed receive orphan drug status

Aug. 23, 2001

Xenova and QLT sign licensing agreement for XR-9576

Aug. 22, 2001

Abgenix and Agensys sign cancer immunotherapy collaboration

Aug. 22, 2001

Addition of ZD-1839 to conventional maintenance therapy being evaluated in NSCLC patients

Aug. 22, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...